Navigation Links
New Parkinson's Drug Draws Mixed Reviews
Date:9/23/2009

Researchers split on whether it slowed disease progression in trial

WEDNESDAY, Sept. 23 (HealthDay News) -- A study to see whether a new drug can stop the progression of Parkinson's disease has produced results that have drawn sharply differing reactions from neurologists.

The drug, rasagiline (Azilect), was approved in 2006 by the U.S. Food and Drug Administration on the basis of studies showing that it reduced Parkinson's symptoms such as trembling and slowed motion. The new study, reported in the Sept. 24 issue of the New England Journal of Medicine, was designed to determine whether the drug also acts on the underlying nerve deterioration that causes the disease.

"In our heart, what we are hoping for is neuroprotection," said study author Dr. C. Warren Olanow, a professor of neurology and neuroscience at Mount Sinai School of Medicine, in New York City.

To distinguish the effect on symptoms from the hoped-for effect on the underlying disease, "we used a totally new study design, to see if it is disease-modifying," Olanow explained.

The study enlisted 1,176 people with previously untreated Parkinson's disease who were seen at medical centers around the world. At the start, half took daily doses of either 1 milligram or 2 milligrams of rasagiline for 36 weeks, while the other half took a placebo. After that, all the participants took either 1 milligram or 2 milligrams of rasagiline for another 36 weeks.

A complex system to measure the treatment effects showed an apparent improvement in the participants who took the 1-milligram doses but not in those taking the 2-milligram doses.

"It did something to affect the course of the disease," Olanow said. "We don't know why, but we are entitled to speculate."

His speculation is based on a detailed study of the 25 percent of participants who showed the greatest benefit. "What I think is right is that the higher dose had a grea
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Food Addicts Convention Draws 800 Members from 31 States, 5 Nations Around the World
2. Misuse of Pain Medication Draws Heightened Concerns
3. Tevas Forum Draws Key Pennsylvania Healthcare Leaders
4. Allscripts User Conference Draws 2,700, Sets Attendance Record
5. Boston Cardinal OMalley Withdraws Caritas Christi From Potential Abortion Scandal
6. Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel
7. Leading US Pediatric Hospital Draws First Dose with RIVA System
8. All Hands On Sweepstakes Thanks, Draws Industry to Web Site
9. Max Muscle Sports Nutrition Franchising Draws Record Interest
10. Schering-Plough Withdraws From Barclays Capital Global Healthcare Conference
11. Dr Timothy Huckabee Free Day of Dental Care Draws a Crowd
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Parkinson's Drug Draws Mixed Reviews
(Date:5/5/2015)... global lab automation market is expected to reach $5,105.7 ... an estimated CAGR of 6.7% from 2015 to 2020. ... basis of equipment and software, application, type of automation, ... Lab Automation Market is classified into clinical diagnostics, drug ... a major application of the lab automation market. Developing ...
(Date:5/5/2015)... 2015 Viverae®, a health management ... a leading multinational developer, manufacturer and marketer of ... vascular, urology, oncology and surgical specialty products, as ... The Vanguard Award recognizes outstanding achievement in the ... Viverae’s significant client base. , Viverae reviewed the ...
(Date:5/5/2015)... Patricia George knows all too well the debilitating effects ... specialist at the University of Pittsburgh Medical Center (UPMC), ... idea entered her mind for Team PHenomenal Hope. ... 2010 PHA International Conference,” George recalled. “The speakers – ... climb up Mt. Kilimanjaro and I remember thinking how ...
(Date:5/5/2015)... 05, 2015 In a April 25, 2015, ... Herald-Times , the Missouri State Highway Patrol (MSHP) announced that ... or use for the second year in a row. ... FBI, reported 1,469 incidents in 2014 alone, around 15% of ... 2% of the US Population calls Indiana home, according to ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 ProTexting, LLC ... enables businesses to deploy Mobile Engagement Campaigns and other ... . ProTexting clients can now leverage the power of ... collecting and syncing subscribers’ e-mail addresses into the Constant ... have recognized that the growing trend of multi-channel marketing ...
Breaking Medicine News(10 mins):Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:World PH Day: Team PHenomenal Hope Races to Spread the Word about Pulmonary Hypertension 2Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3
... , , , ... GPRO ) today reported financial results for the second quarter of ... sexually transmitted disease (STD), clinical diagnostics and total product sales. , ... quarter of 2009 as a good performance from our core STD ...
... , WASHINGTON, JULY 30 An estimated 4.1 million residents ... House health reform bill, according to state-specific analysis of The ... by The Heritage Foundation . , , ... highly respected health care policy and management consulting firm, to examine the ...
... elderly out of hospitals , THURSDAY, July 30 (HealthDay ... in the elderly could help reduce rates of disability ... from a study of 3,011 healthy U.S. residents, aged ... than 55 percent of them were hospitalized at least ...
... , , , DALLAS ... CLAI), a leading provider of Internet-based claims processing solutions for the healthcare ... ended June 30, 2009. , , For the ... increase compared to the $529,000 reported for the second quarter of 2008. ...
... , DALLAS, July 30 When Texas voters ... of Texas (CPRIT), they took a major step forward in making Texas ... fund investing in cutting-edge, Texas-based research and commercialization projects aimed at finding ... privilege for me to be part of CPRIT and to have a ...
... ... a swine (H1N1) flu shot in addition to a seasonal flu shot this fall to ... Prevention,s Vaccine Advisory Committee recommendations July 29 that identified people with asthma as one of ... ...
Cached Medicine News:Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 2Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 3Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 4Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 5Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 6Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 7Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 8Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 9Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 10Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 11Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 12Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 13Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 14Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 15Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 16Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 17Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 18Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 19Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 20Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 21Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 22Health News:Millions of Pennsylvanians Could Lose Private Insurance, Study Shows 2Health News:Muscle Density Linked to Disability 2Health News:Claimsnet.com Reports Second Quarter 2009 Results 2Health News:Claimsnet.com Reports Second Quarter 2009 Results 3Health News:Claimsnet.com Reports Second Quarter 2009 Results 4Health News:Texas on Top of Cancer Research: Dallas Regional Chamber Hosts Forum on New $3 Billion Fund 2Health News:Allergists Urge Asthmatics to Get Swine and Seasonal Flu Shots Following CDC Vaccine Advisory Committee Recommendations 2
(Date:5/5/2015)... BRIDGEWATER, N.J. , May 5, 2015  CorMedix ... developing and commercializing therapeutic products for the treatment of ... 2015 financial results on May 7.  Randy Milby ... investor conference call on Friday, May 8 at 9:00 ... in the conference call, please call 1-877-407-8031 (U.S.), 1-201-689-8031 ...
(Date:5/5/2015)... May 5, 2015 Silver Creek Pharmaceuticals, Inc. ... Research (SBIR) grant from the National Institute of Health ... San Francisco based biotechnology company that ... tissues damaged by disease. This award will be used ... heart tissue following a heart attack. Silver ...
(Date:5/5/2015)... , May 5, 2015  IBM Watson Health (NYSE: ... with more than a dozen leading cancer institutes to ... treatment options for their patients. The institutes will apply ... reduce from weeks to minutes the ability to translate ... relevant information from medical literature to personalize treatment options. ...
Breaking Medicine Technology:CorMedix, Inc. to Report First Quarter Financial Results on May 8, 2015 2Silver Creek Pharmaceuticals Awarded NIH SBIR Grant for Smart Growth Factor Technology 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 5Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 6
... Md., Feb. 10, 2011 Neuralstem, Inc. (NYSE Amex: ... I human clinical trial of the company,s spinal cord stem ... Lou Gehrig,s disease) at Emory University in Atlanta, Georgia. The company ... nine patients, the trial,s Safety Monitoring Board has unanimously approved ...
... On January 26, 2011, it was reported that ... severely by rhabdomyolysis that they were hospitalized.  Occurrences of ... causal factor, such as a drug. Drugs ... known in rare cases to cause rhabdomyolysis.  It seems ...
Cached Medicine Technology:Neuralstem Updates ALS Clinical Trial Progress 2Neuralstem Updates ALS Clinical Trial Progress 3Neuralstem Updates ALS Clinical Trial Progress 4Did ADHD Drugs Cause Muscle Damage in Iowa Football Players? 2
... This unique system uses prolene as thread-guide ... The hollow Ritleng Probe is inserted into the ... fed through it. The probe is then withdrawn ... mm 0.64 mm diam silicone tubing into place. ...
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... Ultra-thin collarette conforms to natural anatomy ... Pre-loaded on disposable inserter/dilator instrument for ease ... Slim Mini and Slim Petite plugs offer ... The Slim plugs are made of the ...
For use with Crawford Intubation Systems....
Medicine Products: